Human Pluripotent Stem Cells: Prospects and Challenges as a Source of Cardiomyocytes for In Vitro Modeling and Cell-Based Cardiac Repair

Hartman and Laflamme provide a perspective on these studies and describe studies to directly reconstitute cardiomyocytes by ex vivo expansion from pluripotent stem cells. Read more.

Related News

Research Insights

In Vitro Matured Human Pluripotent Stem Cell-derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts

January 28, 2022
Research Insights

Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells

May 26, 2021
Press Releases

Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine

May 26, 2021
Research Insights

In Vitro Matured Human Pluripotent Stem Cell-derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts

January 28, 2022
Research Insights

Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells

May 26, 2021
Press Releases

Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine

May 26, 2021